AEF:CA:TSX-Apollo Healthcare Corp (CAD)

COMMON STOCK | Household & Personal Products | TSX

Last Closing Price

CAD 2.19

Change

0.00 (0.00)%

Market Cap

CAD 0.16B

Volume

0.05M

Avg Analyst Target

N/A

Avg User Target

CAD
Average Analyst Rating

N/A

Fundamental Analysis

Verdict


Apollo Healthcare Corp (AEF) Stock Analysis:
Based on the Apollo Healthcare Corp stock forecasts from 0 analysts, the average analyst target price for Apollo Healthcare Corp is not available over the next 12 months. Apollo Healthcare Corp’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Apollo Healthcare Corp is Very Bullish, which is based on 2 positive signals and 0 negative signals. At the last closing, Apollo Healthcare Corp’s stock price was CAD 2.19. Apollo Healthcare Corp’s stock price has changed by +0.00% over the past week, +0.00% over the past month and +0.00% over the last year.

No recent analyst target price found for Apollo Healthcare Corp
No recent average analyst rating found for Apollo Healthcare Corp

About

Acasta Enterprises Inc. is a private equity firm specializing in buyouts. It prefer to invest in founder-led businesses, carve-outs of non-core assets, industry consolidation, and growth-oriented businesses. The firm prefers to invest in private label consumer staples and aviatio ...Read More

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2022-01-19 )

Largest Industry Peers for Household & Personal Products

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
AHC:CA Apollo Healthcare Corp

N/A

CAD0.33B 7.91 3.57
KPT:CA KP Tissue Inc

-0.03 (-0.28%)

CAD0.10B 145.73 N/A
MAV:CA MAV Beauty Brands Inc

-0.03 (-2.50%)

CAD0.05B 6.98 9.64

ETFs Containing AEF:CA

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Household & Personal Products)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 12 Months  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain -77.42% N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return -77.42% N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 40.75% N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 40.75% N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 168.19% N/A N/A N/A N/A
Risk Adjusted Return 24.23% N/A N/A N/A N/A
Market Capitalization 0.16B N/A N/A N/A N/A
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Household & Personal Products)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 6.56 N/A N/A N/A N/A
Price/Book Ratio 4.84 N/A N/A N/A N/A
Price / Cash Flow Ratio 33.10 N/A N/A N/A N/A
EV/EBITDA 5.55 N/A N/A N/A N/A
Management Effectiveness  
Return on Equity N/A N/A N/A N/A N/A
Return on Invested Capital -1.90% N/A N/A N/A N/A
Return on Assets 12.03% N/A N/A N/A N/A
Debt to Equity Ratio 177.16% N/A N/A N/A N/A
Technical Ratios  
Short Ratio 5.97 N/A N/A N/A N/A
Short Percent N/A N/A N/A N/A N/A
Beta 1.17 N/A N/A N/A N/A
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

No discussions yet

User / Independent Analyst Ratings

User Name Target Rating Target Horizon (Months) Target Price User Analysis Date Comment

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:

There is nothing we particularly dislike